Marksans Pharma (MARKSANS.NS) Stock Price
Marksans Pharma Price
Revenue has compounded at 12.1% per year over the past 19 years to 26.23 B INR. Earnings per share have grown at 14.5% per year over the last 19 years. Marksans Pharma's net margin stands at 14.5%, down from 17.1% several years earlier. Marksans Pharma currently offers a dividend yield of about 0.25%. The payout ratio is around 10% of earnings. The dividend has grown at 20.8% per year over the past 11 years. Analysts set a median price target of 237.66 INR, implying 24.9% below the current price. Of 10 analysts, 9 rate the stock a buy — an overall Buy consensus.
Marksans Pharma stock price
Marksans Pharma business model & stock analysis
Frequently asked questions about Marksans Pharma
Analysts currently set an average price target of 237.66 INR for the Marksans Pharma stock (median: 237.66 INR), implying -24.9 % versus the latest price. The consensus is based on 10 analyst ratings.
10 analysts currently rate the Marksans Pharma stock: 9 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Marksans Pharma to generate revenue of 29.00 B INR and earnings per share of 8.57 INR.
Converted at the current exchange rate, the Marksans Pharma share trades at 2.92 EUR (316.40 INR).
The Marksans Pharma share (MARKSANS.NS) is listed on 2 stock exchanges, including: NSE (Indien) (MARKSANS.NS).
The expected revenue of Marksans Pharma is 29.00 B INR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Marksans Pharma is 3.88 B INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Marksans Pharma is currently 36.91. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Marksans Pharma stock.
The price-to-sales ratio (P/S) of Marksans Pharma is currently 4.94. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Marksans Pharma stock.
The Eulerpool Quality Score for Marksans Pharma is 7/10.
The ISIN of Marksans Pharma is INE750C01026. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Marksans Pharma is MARKSANS.NS. The ticker symbol is used to trade Marksans Pharma shares on the stock exchange.
Marksans Pharma stock
Marksans Pharma Peer Group
Marksans Pharma Ticker
Marksans Pharma FIGI
All fundamentals and in-depth analysis of Marksans Pharma
Our stock analysis for Marksans Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Marksans Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.